These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9213068)

  • 1. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia.
    Minthon L; Edvinsson L; Gustafson L
    Dement Geriatr Cogn Disord; 1997; 8(4):232-9. PubMed ID: 9213068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Nilsson CL; Brinkmalm A; Minthon L; Blennow K; Ekman R
    Peptides; 2001 Dec; 22(12):2105-12. PubMed ID: 11786197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia.
    Minthon L; Edvinsson L; Gustafson L
    Alzheimer Dis Assoc Disord; 1996; 10(4):197-203. PubMed ID: 8939279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration.
    Minthon L; Edvinsson L; Ekman R; Gustafson L
    J Neural Transm Suppl; 1990; 30():57-67. PubMed ID: 1975266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs.
    Atack JR; Beal MF; May C; Kaye JA; Mazurek MF; Kay AD; Rapoport SI
    Arch Neurol; 1988 Mar; 45(3):269-74. PubMed ID: 2893600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration.
    Edvinsson L; Minthon L; Ekman R; Gustafson L
    Dementia; 1993; 4(3-4):167-71. PubMed ID: 8401787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
    Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
    Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
    Grossman M; Farmer J; Leight S; Work M; Moore P; Van Deerlin V; Pratico D; Clark CM; Coslett HB; Chatterjee A; Gee J; Trojanowski JQ; Lee VM
    Ann Neurol; 2005 May; 57(5):721-9. PubMed ID: 15852395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
    Heilig M; Sjögren M; Blennow K; Ekman R; Wallin A
    Biol Psychiatry; 1995 Aug; 38(4):210-6. PubMed ID: 8547442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF somatostatin-like immunoreactivity in dementia.
    Beal MF; Growdon JH; Mazurek MF; Martin JB
    Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid neuropeptide Y in Alzheimer's disease.
    Alom J; Galard R; Catalan R; Castellanos JM; Schwartz S; Tolosa E
    Eur Neurol; 1990; 30(4):207-10. PubMed ID: 2209674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease.
    Kaufer DI; Miller BL; Itti L; Fairbanks LA; Li J; Fishman J; Kushi J; Cummings JL
    Neurology; 1997 Apr; 48(4):978-85. PubMed ID: 9109887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlap between frontotemporal dementia and Alzheimer's disease: cerebrospinal fluid pattern and neuroimaging study.
    Padovani A; Premi E; Pilotto A; Gazzina S; Cosseddu M; Archetti S; Cancelli V; Paghera B; Borroni B
    J Alzheimers Dis; 2013; 36(1):49-55. PubMed ID: 23568100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Diamandis EP; Scorilas A; Kishi T; Blennow K; Luo LY; Soosaipillai A; Rademaker AW; Sjogren M
    Clin Biochem; 2004 Mar; 37(3):230-7. PubMed ID: 14972646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative correlation between neuropeptide Y profile in the cerebrospinal fluid and growth hormone pulses in the peripheral circulation in goats.
    Yonezawa T; Mogi K; Li JY; Sako R; Manabe N; Yamanouchi K; Nishihara M
    Neuroendocrinology; 2010; 91(4):308-17. PubMed ID: 20453462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal dementia versus Alzheimer's disease: differential cognitive features.
    Mendez MF; Cherrier M; Perryman KM; Pachana N; Miller BL; Cummings JL
    Neurology; 1996 Nov; 47(5):1189-94. PubMed ID: 8909428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of neuropeptide Y and somatostatin in human cerebrospinal fluid as monitored by radioimmunoassay and mass spectrometry.
    Nilsson C; Westman A; Blennow K; Ekman R
    Peptides; 1998; 19(7):1137-46. PubMed ID: 9786162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.
    Sunderland T; Rubinow DR; Tariot PN; Cohen RM; Newhouse PA; Mellow AM; Mueller EA; Murphy DL
    Am J Psychiatry; 1987 Oct; 144(10):1313-6. PubMed ID: 2889377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
    Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus.
    Poca MA; Mataró M; Sahuquillo J; Catalán R; Ibañez J; Galard R
    J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):298-304. PubMed ID: 11181849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.